Nathan Shumway is an Oncology physician. OpenAlex indexes 57 publications with 992 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
18707 Hardy Oak Blvd
Suite 320
San Antonio, TX 782584791
Telephone
210-545-6972Registry record last updated 28 Jan 2016.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- Immunocore LimitedProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
62.3%Parenteral Iron Replacement38.8%Iron sucrose100%Part B, office-administered≥11 patientsErythropoiesis-stimulating Agent22.6%Darbepoetin alfa100%Part B, office-administered≥11 patients+ 1 more class in this area
Metabolism & gastrointestinal
29.4%Other antiemetics25.2%Fosaprepitant100%Part B, office-administered≥11 patientsSerotonin-3 Receptor Antagonist4.1%Palonosetron hcl67%Granisetron hydrochloride33%Part B, office-administered≥17 patients+ 1 more class in this area
Sensory organs
5.1%Corticosteroid5.1%Dexamethasone sodium phosphate96%Dexamethasone4%Part D + Part B≥30 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Missile Cross-Sectional Shape on Aerodynamic Performance at Supersonic Speeds
Journal of Spacecraft and Rockets
2025 - Aerodynamic Characteristics of Circular and Noncircular Cross-Sectional Missile Configurations
Journal of Spacecraft and Rockets
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”